Articles by Harry G. Brittain, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Harry G. Brittain, PhD

The Path to Product Stability Is through Water

Readers can learn about the importance of measuring and controlling water activity in a comprehensive new book.
Dec 2, 2009

Readers can learn about the importance of measuring and controlling water activity in a comprehensive new book.

Strategy for the Prediction and Selection of Drug Substance Salt Forms

Through consideration of the ionic equilibria of acids and bases, one may readily calculate the formation constant of a salt species solely on the basis of knowledge of the pKA value of the acid and the pKB value of the base.
Oct 2, 2007

Through consideration of the ionic equilibria of acids and bases, one may readily calculate the formation constant of a salt species solely on the basis of knowledge of the pKA value of the acid and the pKB value of the base.

Determination by Analytical Sieving: Particle-Size Distribution, Part III

Dec 2, 2002

The author discusses the use of analytical sieving to determine the size distribution of granular and course powders and describes proper sieve construction and USP General Test {786}.

Particle-Size Distribution II: The Problem of Sampling Powdered Solids

Jul 1, 2002

Dynamic powder-sampling methods may be the best techniques for obtaining a representative sample for determining particle-size distribution.

What Is the "Correct" Method to Use for Particle-Size Determination?

Jul 1, 2001

Appropriate sampling procedures, proper preparation, and correct instrumental parameters may yield differing, but correct, results.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here